⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydroquinone SCHEMBL15516 | 0.71 | — | — | |
| Hydroquinone SCHEMBL460669 | 0.71 | ALOX15 (1.00) | — | |
| Hydroquinone SCHEMBL11511669 | 0.71 | ALOX15 (1.00) | — | |
| SCHEMBL23466995 | 0.69 | LMNA (0.50) | — | |
| SCHEMBL232015 | 0.69 | — | — | |
| SCHEMBL137718 | 0.69 | — | — | |
| Phloroglucinol SCHEMBL11130971 | 0.68 | ALDH1A1 (0.73) | — | |
| Hydroquinone SCHEMBL3191616 | 0.68 | ALOX15 (0.73) | — | |
| SCHEMBL23467126 | 0.67 | NOS3 (0.43) | — | |
| SCHEMBL5450 | 0.67 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-110628302-B | Double-component coating based on modified epoxy resin and preparation method thereof | 浙江鱼童新材料股份有限公司 | 2021-08-24 | — | — | CN | disclosed |
| CN-110628302-A | Double-component coating based on modified epoxy resin and preparation method thereof | 罗洪财 | 2019-12-31 | — | — | CN | disclosed |
| EP-0747354-B1 | 3-Substituted oxindole derivatives as potassium channel modulators | BRISTOL MYERS SQUIBB CO (US) | 2000-08-16 | — | — | EP | disclosed |
| US-5602169-A | USEFUL IN REDUCING NEURONAL DAMAGE DURING ISCHEMIC STROKE | BRISTOL-MYERS SQUIBB COMPANY (US) | 1997-02-11 | — | — | US | disclosed |
| EP-0747354-A1 | 3-Substituted oxindole derivatives as potassium channel modulators | BRISTOL-MYERS SQUIBB COMPANY (US) | 1996-12-11 | — | — | EP | disclosed |
| US-5565483-A | ADMINISTERING AS THERAPY FOR ISCHEMIA, CONVULSIONS OR ASTHMA | BRISTOL-MYERS SQUIBB COMPANY (US) | 1996-10-15 | — | — | US | disclosed |